{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:13:14Z","timestamp":1784239994070,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejso.2026.111949","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:12:03Z","timestamp":1781223123000},"page":"111949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early postoperative intraperitoneal chemotherapy for pseudomyxoma peritoneii: A state of the art review"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3394-2735","authenticated-orcid":false,"given":"Yang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-3700","authenticated-orcid":false,"given":"Ashish","family":"Vaska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0100-1200","authenticated-orcid":false,"given":"Nima","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-374X","authenticated-orcid":false,"given":"Winston","family":"Liauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-8521","authenticated-orcid":false,"given":"David","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2026.111949_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","article-title":"Pseudomyxoma peritonei: natural history and treatment","volume":"33","author":"Mittal","year":"2017","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2026.111949_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.14694\/EdBook_AM.2013.33.221","article-title":"Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei","author":"Buell-Gutbrod","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"10","key":"10.1016\/j.ejso.2026.111949_bib3","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.ejso.2022.06.013","article-title":"Prevalence and incidence of pseudomyxoma peritonei in urban China: a nationwide retrospective cohort study","volume":"48","author":"Feng","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1245\/s10434-020-08655-8","article-title":"Estimating the prevalence of Pseudomyxoma peritonei in Europe using a novel statistical method","volume":"28","author":"Patrick-Brown","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111949_bib5","series-title":"Pseudomyxoma peritonei. StatPearls. Treasure Island (FL): Statpearls Publishing Copyright \u00a9 2025","author":"Yu","year":"2025"},{"issue":"10","key":"10.1016\/j.ejso.2026.111949_bib6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02554625","article-title":"Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment","volume":"30","author":"Sugarbaker","year":"1987","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.ejso.2026.111949_bib7","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.ejso.2022.02.004","article-title":"Morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases with or without early postoperative intraperitoneal chemotherapy: a propensity score matched study","volume":"48","author":"Dranichnikov","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejso.2020.08.026","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: a propensity score analysis","volume":"47","author":"Soucisse","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111949_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.amjsurg.2015.03.008","article-title":"Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis","volume":"210","author":"Lam","year":"2015","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2026.111949_bib10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3389\/fpsyg.2016.01811","article-title":"The development of a checklist to enhance methodological quality in intervention programs","volume":"7","author":"Chac\u00f3n-Moscoso","year":"2016","journal-title":"Front Psychol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/pp-2022-0205","article-title":"Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study","volume":"8","author":"Hayler","year":"2023","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"10.1016\/j.ejso.2026.111949_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.21873\/anticanres.16223","article-title":"Comparing survival outcomes and impact of EPIC in patients undergoing CRS\/HIPEC for mucinous appendiceal neoplasm","volume":"43","author":"Mercado","year":"2023","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.ejso.2026.111949_bib13","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.21873\/anticanres.15370","article-title":"Peritoneal spread of low-grade appendiceal tumours - 2 days of early postoperative intra-peritoneal chemotherapy are enough","volume":"41","author":"Rao","year":"2021","journal-title":"Anticancer Res"},{"issue":"12","key":"10.1016\/j.ejso.2026.111949_bib14","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ejso.2017.09.002","article-title":"Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination","volume":"43","author":"Huang","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1245\/s10434-016-5529-0","article-title":"Early postoperative intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasms with Pseudomyxoma peritonei: is it beneficial?","volume":"24","author":"Huang","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111949_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/02656736.2015.1135485","article-title":"Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?","volume":"32","author":"Tan","year":"2016","journal-title":"Int J Hyperther"},{"issue":"5","key":"10.1016\/j.ejso.2026.111949_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/ans.16627","article-title":"Western Australian Peritonectomy Service: a review of the first 6 years of operation of a low-volume peritonectomy centre","volume":"91","author":"McEntee","year":"2021","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.9738\/INTSURG-D-14-00089.1","article-title":"Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix","volume":"100","author":"Sparks","year":"2015","journal-title":"Int Surg"},{"issue":"4","key":"10.1016\/j.ejso.2026.111949_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/1097-0142(19860815)58:4<826::AID-CNCR2820580403>3.0.CO;2-O","article-title":"5-Fluorouracil chemotherapy and pelvic radiation in the treatment of large bowel cancer. Decreased toxicity in combined treatment with 5-fluorouracil administration through the intraperitoneal route","volume":"58","author":"Sugarbaker","year":"1986","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000421-198602000-00001","article-title":"Prolonged treatment schedules with intraperitoneal 5-fluorouracil diminish the local-regional nature of drug distribution","volume":"9","author":"Sugarbaker","year":"1986","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111949_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00253116","article-title":"High volume intraperitoneal chemotherapy (\"belly bath\") for ovarian cancer. Pharmacologic basis and early results","volume":"1","author":"Jones","year":"1978","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib24","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat Rep"},{"issue":"8","key":"10.1016\/j.ejso.2026.111949_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","article-title":"Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy","volume":"6","author":"Sugarbaker","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111949_bib26","first-page":"141","article-title":"Recurrent intraabdominal cancer with intestinal obstruction","volume":"80","author":"Averbach","year":"1995","journal-title":"Int Surg"},{"key":"10.1016\/j.ejso.2026.111949_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4613-1245-1_10","article-title":"Pseudomyxoma peritonei","volume":"81","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2026.111949_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4613-1245-1_9","article-title":"Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"81","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.ejso.2026.111949_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4251\/wjgo.v2.i1.19","article-title":"Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer","volume":"2","author":"Sugarbaker","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111949_bib30","first-page":"545","article-title":"[Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia with mitomycin C. Initial experience]","volume":"44","author":"Gilly","year":"1990","journal-title":"Ann Chir"},{"issue":"2","key":"10.1016\/j.ejso.2026.111949_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000011847","article-title":"Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-Fluorouracil: Pharmacokinetic studies","volume":"55","author":"Jacquet","year":"1998","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.ejso.2026.111949_bib32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","article-title":"Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique","volume":"6","author":"Stephens","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111949_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/bjs.4609","article-title":"Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin","volume":"91","author":"Mahteme","year":"2004","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.ejso.2026.111949_bib34","first-page":"407","article-title":"[Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy]","volume":"27","author":"Elias","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111949_bib35","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1245\/s10434-009-0341-8","article-title":"Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution","volume":"16","author":"Chua","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111949_bib36","doi-asserted-by":"crossref","first-page":"iv79","DOI":"10.1093\/annonc\/mdt203.151","article-title":"Peritonectomy Results at St.George Hospital, Sydney, Australia at 677 procedures","volume":"24","author":"Kirby","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111949_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/pubmed\/fdl048","article-title":"Decision-making and technical factors account for the learning curve in complex surgery","volume":"28","author":"Moran","year":"2006","journal-title":"J Publ Health"},{"issue":"8","key":"10.1016\/j.ejso.2026.111949_bib38","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ejso.2014.03.001","article-title":"Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve","volume":"40","author":"Andr\u00e9asson","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111949_bib39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/codi.12975","article-title":"The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy","volume":"17","author":"Moran","year":"2015","journal-title":"Colorectal Dis"},{"issue":"7","key":"10.1016\/j.ejso.2026.111949_bib19","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ejso.2022.02.002","article-title":"Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: a single institution experience","volume":"48","author":"Fung","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2026.111949_bib40","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111949_bib41","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bja.2023.08.032","article-title":"Outcomes following perioperative red blood cell transfusion in patients undergoing elective major abdominal surgery: a systematic review and meta-analysis","volume":"131","author":"Morris","year":"2023","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.ejso.2026.111949_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jso.23276","article-title":"HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy","volume":"107","author":"McConnell","year":"2013","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111949_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jso.27464","article-title":"Use of early postoperative intraperitoneal 5-fluorouracil with index cytoreduction improves survival with secondary cytoreductive surgery","volume":"129","author":"Sugarbaker","year":"2024","journal-title":"J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326005688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:49:14Z","timestamp":1784238554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326005688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0748798326005688"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111949","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early postoperative intraperitoneal chemotherapy for pseudomyxoma peritoneii: A state of the art review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111949"}}